DGX vs EPAM · P/E 22, rev $5.94B vs P/E 14, rev $2.81B
Quest Diagnostics Incorporated (DGX) versus EPAM Systems Inc (EPAM) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported EPAM revenue for 2026-06-30 was $2.81B. Net income was $185.5M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
Not investment advice. Open the DGX and EPAM stock pages for the full models.
Not investment advice.